Protocol for initiation of miglustat treatment in NP-C. Reproduced
Por um escritor misterioso
Descrição
Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry, Orphanet Journal of Rare Diseases
Miglustat - wikidoc
Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia
A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1, Lipids in Health and Disease
Miglustat
A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1, Lipids in Health and Disease
Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice
Estimated prevalence of Niemann–Pick type C disease in Quebec
Protocol for initiation of miglustat treatment in NP-C. Reproduced with
Protocol for initiation of miglustat treatment in NP-C. Reproduced with
Recommendations for oral treatment for adult patients with type 1 Gaucher disease
de
por adulto (o preço varia de acordo com o tamanho do grupo)
